Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

A Adler, L Agodoa, A Algra, FW Asselbergs, NS Beckett, E Berge, H Black, FPJ Brouwers, M Brown, CJ Bulpitt, RP Byington, J Chalmers, WC Cushman, J Cutler, BR Davis, RB Devereaux, J Dwyer, R Estacio, R Fagard, K FoxT Fukui, AK Gupta, RR Holman, Y Imai, M Ishii, S Julius, Y Kanno, SE Kjeldsen, J Kostis, K Kuramoto, J Lanke, E Lewis, JB Lewis, M Lievre, LH Lindholm, S Lueders, S MacMahon, G Mancia, M Matsuzaki, MH Mehlum, S Nissen, H Ogawa, T Ogihara, T Ohkubo, CR Palmer, A Patel, CJ Pepine, MA Pfeffer, B Pitt, NR Poulter, H Rakugi, G Reboldi, C Reid, G Remuzzi, P Ruggenenti, T Saruta, J Schrader, R Schrier, P Sever, P Sleight, JA Staessen, H Suzuki, L Thijs, K Ueshima, S Umemoto, WH van Gilst, P Verdecchia, K Wachtell, P Whelton, L Wing, M Woodward, Y Yui, S Yusuf, A Zanchetti, ZY Zhang, C Anderson, C Baigent, BM Brenner, R Collins, D de Zeeuw, J Lubsen, E Malacco, B Neal, V Perkovic, A Rodgers, P Rothwell, G Salimi-Khorshidi, J Sundström, F Turnbull, G Viberti, J Wang

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1625-1636
Number of pages12
JournalThe Lancet
Volume397
Issue number10285
DOIs
Publication statusPublished - 1 May 2021

Cite this